Mylan Edges Toward Glaxo Drugs

U.S. generic drugs company Mylan, as well as some private-equity groups and Indian drug makers, has made it through to the second round of bidding for a portfolio of mature drugs being sold by GlaxoSmithKline.



from WSJ.com: US Business http://ift.tt/1kV8bv9

via IFTTT